The State Council ordered: 'convenience store drug sales' nationwide rollout!
On August 28, the General Office of the State Council issued the "Opinions on Accelerating the Development of Circulation to Promote Commercial Consumption" (hereinafter referred to as "Opinions"), which put forward 20 policy measures to stabilize consumption expectations and boost consumer confidence. Among them, it is clearly mentioned to accelerate the development of chain convenience stores, to carry out pilot procedures to simplify the approval of tobacco and Class B non-prescription drug operations. In other words, convenience stores selling drugs, to accelerate the country. According to data from the China Tobacco Industry Association, China has a total of 5 million small supermarkets, department stores, convenience stores, grocery stores and other retail outlets for everyday goods. But there may not be as many, but no less, if you count real convenience stores with modern operations and full services.
According to the latest China Convenience Store Development Report 2019 released by KPMG China and China Chain Store Association, there were more than 120,000 convenience store stores in 2018, with an industry growth rate of 19%. In other words, once all convenience stores nationwide sell drugs, at least 120,000 convenience stores will join the battle for the over-the-counter drug market.
2026-10-22
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
Biocytogen announces the launch of the 'Nano 100 Project' to develop fully human therapeutic nanobodies against 100+ targets
-
Wantai Biotech 20-valent pneumonia vaccine started clinical trials, how far is domestic substitution?
-
Yiming Cell 'Suspension 293XS Cell Bank' completed DMF filing with the US FDA
-
The phase III clinical study of Junshi Biologics in combination with teripulimab in the treatment of advanced triple-negative breast cancer reached the primary endpoint
-
The next bombshell: 'PD-1 + ADC', Kelun, Hengrui are going to win numbness?
-
L-Rotator Biotech completed its pre-A financing and continued to increase its investment in the CGT field
-
Hainan to promote drug import facilitation
-
Enable the 'export of EU APIcertification documents' and 'pharmaceutical export salescertificate' electronic proof
-
China to focus on building quality and efficient TCM service system in next five years
Recommend Reading
-
A Fake Email Drains RMB 12 Million: Asia’s Waterproof Giant’s Overseas ‘Payment Heist’ Exposes the Fatal Blind Spot of Chinese Corporate Globalization
-
The FDA Officially Blesses AI for Liver Drug Development
-
U.S. FDA Opens New Safety Review of RSV Treatments for Infants
-
关于进一步规范化学品信息发布、加强全球管制目录宣导的公告 Announcement on Further Standardizing the Release of Chemical Information and Strengthening Public Awareness of Global Control Lists
-
FDA Dye Tracker Raises Reformulation Pressure Across Food Brands
-
This Week's Isopropanol Market Prices Remain Stable (12.22-12.26)
-
Business Society October 15, 2026 Ethanol Trend Analysis: Strong Consolidation
-
Oil Coke to Rise Sharply in 2025, Likely to Experience Relatively Strong Volatility in 2026
-
December China titanium dioxide market rises
-
Business Society October 15, 2026 Methanol Trend Analysis: Bearish Oscillations